P1060: REAL-WORLD CLINICAL OUTCOMES AFTER 3 AND 6 MONTHS OF TREATMENT WITH FEDRATINIB FOLLOWING RUXOLITINIB FAILURE - J. Mascarenhas; A. T. Gerds; J. K. Kish; P. Abraham; A. Balanean; J. A. Nadal; D. Liassou; B. A. Feinberg; A. McBride; C. Harrison (HemaSphere, 2022)